172 related articles for article (PubMed ID: 26305274)
1. Valproic Acid Induces the Hyperacetylation of P53, Expression of P53 Target Genes, and Markers of the Intrinsic Apoptotic Pathway in Midorganogenesis Murine Limbs.
Paradis FH; Hales BF
Birth Defects Res B Dev Reprod Toxicol; 2015 Oct; 104(5):177-83. PubMed ID: 26305274
[TBL] [Abstract][Full Text] [Related]
2. Exposure to valproic acid inhibits chondrogenesis and osteogenesis in mid-organogenesis mouse limbs.
Paradis FH; Hales BF
Toxicol Sci; 2013 Jan; 131(1):234-41. PubMed ID: 23042728
[TBL] [Abstract][Full Text] [Related]
3. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Class-Specific Histone Deacetylase Inhibitors on the Development of Limbs During Organogenesis.
Paradis FH; Hales BF
Toxicol Sci; 2015 Nov; 148(1):220-8. PubMed ID: 26251326
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation.
Kawano T; Akiyama M; Agawa-Ohta M; Mikami-Terao Y; Iwase S; Yanagisawa T; Ida H; Agata N; Yamada H
Int J Oncol; 2010 Oct; 37(4):787-95. PubMed ID: 20811699
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation.
Tsolmongyn B; Koide N; Odkhuu E; Haque A; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Cell Immunol; 2013 Apr; 282(2):100-5. PubMed ID: 23770718
[TBL] [Abstract][Full Text] [Related]
7. VPA-related axial skeletal defects and apoptosis: a proposed event cascade.
Di Renzo F; Broccia ML; Giavini E; Menegola E
Reprod Toxicol; 2010 Jan; 29(1):106-12. PubMed ID: 19850124
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
9. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
Jergil M; Forsberg M; Salter H; Stockling K; Gustafson AL; Dencker L; Stigson M
Toxicol Sci; 2011 Jun; 121(2):328-42. PubMed ID: 21427059
[TBL] [Abstract][Full Text] [Related]
10. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
[TBL] [Abstract][Full Text] [Related]
11. Effects of ethylene glycol monomethyl ether and its metabolite, 2-methoxyacetic acid, on organogenesis stage mouse limbs in vitro.
Dayan C; Hales BF
Birth Defects Res B Dev Reprod Toxicol; 2014 Jun; 101(3):254-61. PubMed ID: 24798094
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific effects of valproic acid on DNA repair genes and apoptosis in postimplantation mouse embryos.
Lamparter C; Winn LM
Toxicol Sci; 2014 Sep; 141(1):59-67. PubMed ID: 24913804
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modifications in valproic acid-induced teratogenesis.
Tung EW; Winn LM
Toxicol Appl Pharmacol; 2010 Nov; 248(3):201-9. PubMed ID: 20705080
[TBL] [Abstract][Full Text] [Related]
14. Polycomb homologs are involved in teratogenicity of valproic acid in mice.
Okada A; Aoki Y; Kushima K; Kurihara H; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):870-9. PubMed ID: 15523661
[TBL] [Abstract][Full Text] [Related]
15. The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines.
Chang YL; Huang LC; Chen YC; Wang YW; Hueng DY; Huang SM
Int J Biochem Cell Biol; 2017 Nov; 92():155-163. PubMed ID: 29017950
[TBL] [Abstract][Full Text] [Related]
16. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
[TBL] [Abstract][Full Text] [Related]
17. The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations.
Moallem SA; Hales BF
Development; 1998 Aug; 125(16):3225-34. PubMed ID: 9671594
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects.
Tung EW; Winn LM
Mol Pharmacol; 2011 Dec; 80(6):979-87. PubMed ID: 21868484
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation.
Zhang Z; Qin X; Tong N; Zhao X; Gong Y; Shi Y; Wu X
Exp Eye Res; 2012 Jan; 94(1):98-108. PubMed ID: 22143029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]